PTO/AiA/15 (10-17)
`Approved for use through 11/30/2020. OMB 0651—0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`
`
`[mu-W
`
`
`
`Power of Attorney
`
`Nonpublication Request
`Under 35 U.S.C. 122(b)(2)(B)(i). Applicant must attach form PTO/SB/35
`or equivalent.
`
`11'
`
`
`
`
`
`17_
`
`
`
`
`
`
`
`PATENT APPL,CAT,ON
`7.."
`SPEECH RECOGNITION CIRCUIT USING PARALLEL
`
`
`TRANSMITTAL
`’ e
`PROCESSORS
`__LabelNo.
`(Only for new nonprovisiona/ applications under 37 CFR 1.53(b))
`
`
`Commissioner for Patents
`
`APPLICATION ELEMENTS
`P.O. Box 1450
`ADDRESS TO:
`
`See MPEP chapter 600 concerning utility patent application contents.
`Alexandria, VA 22313-1450
`
`
`
`Fee Transmittal Form
`
`ACCOMPANYING APPLICATION PAPERS
`
`(PTO/SB/17 or equivalent)
`
`
`
`'
`See 37 CFR 1.27
`10. D Assignment Papers
`2 ' E Applicant asserts small entity status.
`
`
`(cover sheet & document(s))
`
`
`
`
`3
`Applicant certifies micro entity status. See 37 CFR 1.29.
`'
`Applicant must attach form PTO/SB/15A or B or equivalent.
`
`
`4. IE Specification
`[Total Pages
`19
`I
`Name of Assignee
`
`
`
`Both the claims and abstract must start on a new page.
`(See MPEP § 6‘08.01(a) iorinformation on the preferred arrangement)
`
`Drawing(s) (35 U.S.C. 113)
`[Total Sheets
`]
`
`,
`.
`37 CFR 3.73(c) Statement
`
`
`
`(when there is an assignee)
`]
`1
`[Total Pages
`6. Inventor s Oath or Declaration
`(including substitute statements under 37 CFR 1.64 and assignments
`
`
`
`serving as an oath or declaration under 37 CFR 1,63(e))
` 12. __I English Translation Document (ifapplicable)
`
`
`13 X Information Disclosure Statement
` Newly executed (original or copy)
`
`' __ (PTO/SB/OB or PTO-1449)
`
`
`
`
`A copy from a prior application (37 CFR 1.63(d))
`D Copies of citations attached
`
`
`* See note below.
`14. '2 Preliminary Amendment
`7. E Application Data Sheet
`
`
`
`See 37 CFR 1.76 (PTO/AlA/14 or equivalent)
`
`CD-ROM or CD—R
`
`15‘ E Return Receipt Postcard
`
`(MPEP § 503) (Should be specifically itemized)
`in duplicate, large table, or Computer Program (Appendix)
`
`3 Landscape Table on CD
`9_ Nucleotide and/or Amino Acid Sequence Submission
`Certified Copy of Priority Document(s)
`16.
`
`(if foreign priority is claimed)
`
`
`(if applicable, items a. — c. are required)
`
`
`a. :I Computer Readable Form (CRF)
`
`
`
`
`
`b. :I Specification Sequence Listing on:
`
`
`. ::| Other:
`i. CI CD-ROM or CD-R (2 copies); or
`
`ii. CI Paper
`
`. :l Statements verifying identity of above copies
`
`
`(1) Benefit claims under 37 CFR 1.78 and foreign priority claims under 1.55 must be included in an Application Data Sheet (ADS).
`*Note:
`
`
`(2) For applications filed under 35 U.S.C. 111, the application must contain an ADS specifying the applicant if the applicant is an
`assignee, person to whom the inventor is under an obligation to assign, or person who otherwise shows sufficient proprietary
`interest in the matter. See 37 CFR 1.46 b .
`
`
` 19. CORRESPONDENCE ADDRESS
`The address associated with Customer Number:
`24998
`OR
`:I Correspondence address below
`
`
`
`||1825 Eye Street, NW
`
`
`
`
`202 420-2200
`US
`
`
`
`Signature
`
`[i
`‘ _ Q,
`.7
`. I,
`Date
`
`
`
`Name
`
`Registration No.
`
`
`(Attorney/Agent)
`Stephen A. Soffen
`(Print/Type)
`
`
`
`8.
`
`
`
`
`
`
`
`
`
`
`Stephen A. Soffen
`BLANK ROME LLP
`
`
`
`_,
`
`20006-5403
`
`February 4, 2019
`
`31,063
`
`149369.00101/117148002v.1
`
`